CorMedix Inc. | 2013 | FY | 3


    Number of Warrants     Exercise Price   Expiration Date

Issued to co-placement agents in connection with previous

     convertible note financings

    18,250     $ 7.84  

 

10/29/2014

Issued in connection with 2009 private placement     503,034       3.4375   10/29/2014
Issued in connection with IPO     4,043,569       3.4375   3/24/2015

Issued to IPO underwriters that, if exercised, would result in the

     issuance of an additional 4,812 shares of common stock and

     warrants to purchase an additional 2,406 shares of common

     stock

        4,812           3.90  

 

 

 

3/24/2015

Issued in connection with September 20, 2012 private placement

     of convertible notes

    2,125,000       0.40  

 

9/20/2017

Issued to placement agent in connection with September 20,

     2012 private placement of convertible notes

    15,420       0.40  

 

9/20/2017

Issued in connection with November 13, 2012 private placement

     of convertible notes

    375,000       0.40  

 

11/13/2017

Issued to placement agent in connection with November 13,

     2012 private placement of convertible notes

     85,167       0.40  

 

11/13/2017

Issued in connection with February 2013 private placement

     of Series A convertible preferred stock

    400,000       1.50  

 

2/19/2018

Issued in connection with license agreement amendment     125,000       1.50   4/11/2018

Issued in connection with July 2013 private placement

     of Series B convertible preferred stock

    227,273       1.50  

 

7/30/2018

Issued in connection with May 2013 private placement

     of convertible notes, which funded in July 2013

    1,000,000       1.00  

 

5/30/2019

Issued in connection with October 2013 private placement

     of Series C-1 and C-2 convertible preferred stock

     1,500,000       1.25  

 

10/22/2019

Total warrants outstanding at December 31, 2013     10,422,525            

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock